AR087811A1 - Vacuna contra el staphylococcus aureus - Google Patents
Vacuna contra el staphylococcus aureusInfo
- Publication number
- AR087811A1 AR087811A1 ARP120103309A ARP120103309A AR087811A1 AR 087811 A1 AR087811 A1 AR 087811A1 AR P120103309 A ARP120103309 A AR P120103309A AR P120103309 A ARP120103309 A AR P120103309A AR 087811 A1 AR087811 A1 AR 087811A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- staphylococcus aureus
- vaccine against
- against staphylococcus
- ssl3
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se refiere al campo de la vacunología, especialmente de vacunas contra Staphylococcus aureus, tanto para aplicación en seres humanos como en el campo veterinario. En particular, se refiere a una proteína similar al súper antígeno estafilocócico 3 (SSL3, por sus siglas en inglés), o su homólogo, o un fragmento inmunogénico de cualquier proteína, para su uso en una vacuna contra S. aureus. Del mismo modo, se refiere a vacunas, métodos y usos médicos de estas proteínas. Reivindicación 1: Una proteína similar al súper antígeno estafilocócico 3 (SSL3), o un homólogo de dicha proteína SSL3, o un fragmento inmunogénico de cualquier proteína, para su uso en una vacuna contra Staphylococcus aureus.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11180633 | 2011-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR087811A1 true AR087811A1 (es) | 2014-04-16 |
Family
ID=46851966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120103309A AR087811A1 (es) | 2011-09-08 | 2012-09-07 | Vacuna contra el staphylococcus aureus |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20140248273A1 (es) |
| AR (1) | AR087811A1 (es) |
| AU (1) | AU2012306282A1 (es) |
| WO (1) | WO2013034682A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015000022A1 (en) * | 2013-07-05 | 2015-01-08 | Adelaide Research & Innovation Pty Ltd | Treatment and prevention of mastitis |
| CN109942719A (zh) * | 2019-05-07 | 2019-06-28 | 中国人民解放军陆军军医大学第二附属医院 | 一种金黄色葡萄球菌融合蛋白及其蛋白表达载体和纯化方法 |
| SE2200142A1 (en) * | 2022-12-13 | 2024-06-14 | Savacc Ab | Chrisvacc |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| WO1986006487A1 (en) | 1985-04-22 | 1986-11-06 | Commonwealth Serum Laboratories Commission | Method for determining mimotopes |
| ATE115862T1 (de) | 1989-02-04 | 1995-01-15 | Akzo Nobel Nv | Tocole als impfstoffadjuvans. |
| FR2714074B1 (fr) | 1993-12-20 | 1996-03-01 | Pasteur Institut | Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs. |
| IL120202A (en) | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| JP2005532405A (ja) | 2002-07-10 | 2005-10-27 | アクゾ・ノベル・エヌ・ベー | 融合タンパク質とサポニンアジュバントとを含む免疫原性組成物 |
| WO2005092918A2 (en) | 2004-03-22 | 2005-10-06 | University College London | Targeting polypeptide |
| WO2005090381A1 (en) * | 2004-03-24 | 2005-09-29 | Auckland Uniservices Limited | Set1 proteins and uses therefor |
| TWI398272B (zh) | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| WO2007118687A2 (en) * | 2006-04-13 | 2007-10-25 | Umc Utrecht Holding Bv | Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| EP2400984A4 (en) | 2009-02-25 | 2013-01-23 | Merck Sharp & Dohme | HER2 ANTIBODY COMPOSITIONS |
-
2012
- 2012-09-07 WO PCT/EP2012/067500 patent/WO2013034682A1/en active Application Filing
- 2012-09-07 AR ARP120103309A patent/AR087811A1/es unknown
- 2012-09-07 AU AU2012306282A patent/AU2012306282A1/en not_active Abandoned
- 2012-09-07 US US14/343,079 patent/US20140248273A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140248273A1 (en) | 2014-09-04 |
| WO2013034682A1 (en) | 2013-03-14 |
| AU2012306282A1 (en) | 2014-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
| CO6640254A2 (es) | Método para preparar anticuerpos con propiedades mejoradas | |
| MX2017009308A (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| CL2017003151A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| AR096113A1 (es) | Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados | |
| CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
| PH12015500092A1 (en) | Compositions for immunising against staphylococcus aureus | |
| AR091316A1 (es) | Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos | |
| AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
| BR112013012555A2 (pt) | peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes | |
| EA201891124A2 (ru) | Новые мукозные адъюванты и системы доставки | |
| UA114286C2 (uk) | Спосіб лікування staphylococcus aureus | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| UY36262A (es) | Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso | |
| BR112015023738B8 (pt) | Vacinas de nucleoproteina influenza | |
| DOP2014000140A (es) | Preparaciones que comprenden emodépsido amorfo | |
| PH12015502844A1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
| AR087811A1 (es) | Vacuna contra el staphylococcus aureus | |
| BR112013019924A2 (pt) | composições para cuidado oral | |
| BR112012018840A2 (pt) | proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |